120
Participants
Start Date
January 23, 2018
Primary Completion Date
June 1, 2026
Study Completion Date
June 1, 2027
Biospecimen Collection
Undergo collection of blood samples
Intensity-Modulated Radiation Therapy
Undergo IMRT
Laboratory Biomarker Analysis
Correlative studies
Magnetic Resonance Imaging
Undergo MRI
Proton Beam Radiation Therapy
Undergo proton beam radiation therapy
Quality-of-Life Assessment
Ancillary studies
Questionnaire Administration
Ancillary studies
Temozolomide
Drug
Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
University of Pennsylvania/Abramson Cancer Center, Philadelphia
UM Upper Chesapeake Medical Center, Bel Air
Central Maryland Radiation Oncology in Howard County, Columbia
UM Baltimore Washington Medical Center/Tate Cancer Center, Glen Burnie
Maryland Proton Treatment Center, Baltimore
University of Maryland/Greenebaum Cancer Center, Baltimore
Emory Proton Therapy Center, Atlanta
Emory University Hospital Midtown, Atlanta
Emory University Hospital/Winship Cancer Institute, Atlanta
Miami Cancer Institute, Miami
Boca Raton Regional Hospital, Boca Raton
University of Alabama at Birmingham Cancer Center, Birmingham
Case Western Reserve University, Cleveland
University Hospitals Parma Medical Center, Parma
University Hospitals Portage Medical Center, Ravenna
Mayo Clinic in Rochester, Rochester
Northwestern Medicine Cancer Center Delnor, Geneva
Northwestern Medicine Cancer Center Warrenville, Warrenville
Northwestern University, Chicago
Washington University School of Medicine, St Louis
University of Kansas Cancer Center - Lee's Summit, Lee's Summit
University of Kansas Cancer Center at North Kansas City Hospital, North Kansas City
University of Kansas Cancer Center - North, Kansas City
Mercy Hospital Springfield, Springfield
University of Kansas Cancer Center, Kansas City
University of Kansas Hospital-Westwood Cancer Center, Westwood
University of Kansas Cancer Center-Overland Park, Overland Park
University of Oklahoma Health Sciences Center, Oklahoma City
M D Anderson Cancer Center, Houston
FHCC at Northwest Hospital, Seattle
University of Washington Medical Center - Montlake, Seattle
MaineHealth Maine Medical Center- Scarborough, Scarborough
Massachusetts General Hospital Cancer Center, Boston
Lead Sponsor
National Cancer Institute (NCI)
NIH
NRG Oncology
OTHER